Provention Bio, Inc.
P.O. Box 666
Oldwick, NJ 08858
August 7, 2019
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Provention Bio, Inc. | |
Registration Statement on Form S-3 (File No. 333-232995) | ||
Filed on August 2, 2019 |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Provention Bio, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission (the “Commission”) at 4:30 p.m., Eastern Standard Time, on August 8, 2019, or as soon as practicable thereafter.
Please call Steven M. Skolnick of Lowenstein Sandler LLP at (973) 597-2476 to confirm the effectiveness of the Registration Statement or with any questions.
[Signature page follows.]
U.S. Securities and Exchange Commission
August 7, 2019
Page 2
Very truly yours, | ||
PROVENTION BIO, INC. | ||
By: | /s/ Andrew Drechsler | |
Name: | Andrew Drechsler | |
Title: | Chief Financial Officer |
-2- |